Datum Källa Rubrik Typ Alternativ
2024-04-24 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Årsredovisning 2023 Rapporter Ladda ner | Visa Stäng
2024-03-01 Redeye Redeye: Klaria Pharma Q4 - Eyes on the prize Pressreleaser Ladda ner | Visa Stäng
2024-02-29 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Year-End Report 2023 Rapporter Ladda ner | Visa Stäng
2024-02-29 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Bokslutskommuniké Q4 2023 Rapporter Ladda ner | Visa Stäng
2024-02-26 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria accelerates its business development efforts Pressreleaser Ladda ner | Visa Stäng
2024-02-26 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria accelererar sitt affärsutvecklingsarbete Pressreleaser Ladda ner | Visa Stäng
2023-12-20 Klaria Pharma Holding Klaria Pharma Holding AB har avslutat första delen av en bryggfinansiering på 6 MSEK av totalt 15 MSEK Pressreleaser Ladda ner | Visa Stäng
2023-11-27 Penser Future Penser Future: Mot ett nytt år med en ny VD - Klaria Pharma Holding Pressreleaser Visa Stäng
2023-11-27 Redeye Redeye: Klaria Pharma Q3 2023 - Take-off is on the horizon Pressreleaser Ladda ner | Visa Stäng
2023-11-24 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Delårsrapport Q3 2023 Rapporter Ladda ner | Visa Stäng
2023-11-24 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Interim Report Q3 2023 Rapporter Ladda ner | Visa Stäng
Rapporter | 24 Nov 2023 | Klaria Pharma

Klaria Pharma Holding AB: Klaria Interim Report Q3 2023

Summary of the Interim Report

Net sales of 0.6 MSEK (0.0 MSEK)

Other income amounted to 0.0 MSEK (0.0 MSEK)

Third quarter of 2023

– R&D costs for the period amounted to 7.4 MSEK (10.9 MSEK)

– Profit after tax amounted to -10.8 MSEK (16.1 MSEK) ∞ Earnings per share for the quarter amounted to -0.10 SEK (-0.27 SEK)

– Cash flow from operating activities amounted to -7.3 MSEK (-3.6 MSEK)

– Cash and cash equivalents on the balance sheet date amounted to 2.3 MSEK (6.7 MSEK)

– Cash and cash equivalents on the balance sheet date amounted to 50.7 MSEK (39.3 MSEK)

The period January-September 2023

– Net sales of 7.1 MSEK (3.7 MSEK)

– Other income amounted to 0.3 MSEK (0.4 MSEK)

– R&D costs for the period amounted to 23.0 MSEK (42.7 MSEK)

– Profit after tax amounted to -26.3 MSEK (-50.9 MSEK)

– Earnings per share for the quarter amounted to -0.27 SEK (-0.88 SEK)

– Cash flow from operating activities amounted to -18.6 MSEK (-39.1 MSEK)

2023-10-25 Klaria Pharma Holding Klaria Pharma Holding AB: Klarias styrelse meddelar att Scott Boyer är ny VD för bolaget Pressreleaser Ladda ner | Visa Stäng
2023-10-25 Klaria Pharma Holding Klaria Pharma Holding AB: Klarias styrelse meddelar att vd Jesper Wiklund lämnar bolaget Pressreleaser Ladda ner | Visa Stäng
2023-10-25 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria's board of directors announces that CEO Jesper Wiklund leaves the company Pressreleaser Ladda ner | Visa Stäng
2023-08-29 Redeye Redeye: Klaria Pharma Q2 - Focus on sealing the deal Pressreleaser Ladda ner | Visa Stäng
2023-08-28 Penser Future Penser Future: Arbetet fortlöper enligt plan - Klaria Pharma Holding Pressreleaser Visa Stäng
2023-08-25 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Delårsrapport Rapporter Ladda ner | Visa Stäng
2023-08-25 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Interim Report Rapporter Ladda ner | Visa Stäng
2023-05-16 Penser Future Penser Future: I väntan på EMA-beslut - Klaria Pharma Pressreleaser Visa Stäng
2023-05-16 Redeye Redeye: Klaria Pharma Holding Q1 2023 - No headache just yet Pressreleaser Ladda ner | Visa Stäng
2023-05-12 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Delårsrapport Q1 2023 Rapporter Ladda ner | Visa Stäng
2023-05-12 Klaria Pharma Holding Klaria Pharma Holding AB: Klaria Interim Report Q1 2023 Rapporter Ladda ner | Visa Stäng
2023-05-12 Klaria Pharma Holding Bulletin from the annual general meeting in Klaria Pharma Holding AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-05-12 Klaria Pharma Holding Kommuniké från årsstämma i Klaria Pharma Holding AB (publ) Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

15 May 2024 | Årsstämma 2023
16 May 2024 | Kvartalsrapport 2024-Q1
22 Aug 2024 | Kvartalsrapport 2024-Q2
21 Nov 2024 | Kvartalsrapport 2024-Q3